Norwich Ventures

IonPath Inc., established in 2014 and headquartered in Menlo Park, California, specializes in multiplexed ion beam imaging services for pathology. The company's core technology surpasses light microscopy, enabling it to analyze fresh, frozen, or FFPE tissues with high precision. This allows healthcare providers to diagnose cancer more accurately, ultimately improving human health through better insights into the tissue microenvironment at a single-cell level.

Podimetrics, Inc. is a healthcare technology company specializing in the prevention of diabetic foot ulcers, a significant complication of diabetes. Founded in 2011 and based in Somerville, Massachusetts, Podimetrics has developed the SmartMat, a wireless in-home monitoring system that enables patients to scan their foot temperature for just 20 seconds each day. This data is automatically transmitted to a dedicated care management team, which monitors for any concerning findings. By integrating advanced technology with effective clinical support, Podimetrics enhances patient engagement and helps clinicians achieve better health outcomes, ultimately saving limbs, lives, and healthcare costs. The company was founded by a physician and engineers from prestigious institutions, reflecting its commitment to innovation in diabetes care management.

Podimetrics, Inc. is a healthcare technology company specializing in the prevention of diabetic foot ulcers, a significant complication of diabetes. Founded in 2011 and based in Somerville, Massachusetts, Podimetrics has developed the SmartMat, a wireless in-home monitoring system that enables patients to scan their foot temperature for just 20 seconds each day. This data is automatically transmitted to a dedicated care management team, which monitors for any concerning findings. By integrating advanced technology with effective clinical support, Podimetrics enhances patient engagement and helps clinicians achieve better health outcomes, ultimately saving limbs, lives, and healthcare costs. The company was founded by a physician and engineers from prestigious institutions, reflecting its commitment to innovation in diabetes care management.

Affera, Inc. is a medical technology company founded in 2013 and based in Watertown, Massachusetts. It focuses on developing innovative solutions for the treatment of cardiac arrhythmia, a common condition that affects millions of patients globally. The company is engaged in the design and development of a novel medical system aimed at addressing the unmet needs in the treatment of heart rhythm disorders. Through its advancements, Affera seeks to enhance the capabilities of healthcare institutions in managing and treating these conditions effectively.

ReThink Medical, Inc. is a medical device and digital health company based in San Francisco, California, founded in 2010. The company specializes in the development of wrist-worn monitoring devices designed to predict and prevent hospitalizations due to heart failure. Their flagship product, CorBand™, utilizes advanced algorithms and artificial intelligence to continuously monitor physiological indicators such as heart rate and fluid status. This technology enables early detection of worsening heart conditions, potentially weeks in advance of noticeable symptoms. By focusing on compliance and ease of use, ReThink Medical aims to provide proactive management of heart failure patients, improving their quality of life while reducing healthcare costs associated with emergency interventions. In 2020, ReThink Medical became a subsidiary of Terumo Corporation.

Pelvalon is a medical device company focused on improving the quality of life for women experiencing fecal incontinence. The company develops innovative, non-surgical therapy devices aimed at addressing the challenges associated with pelvic and bowel health. By providing a treatment option that does not involve drugs or hormones, Pelvalon offers a solution for women suffering from accidental bowel leakage, helping them regain bowel control and enhance their overall well-being.

Lexington Medical is a medical device company based in Watertown, Massachusetts, founded in 2013. The company specializes in manufacturing minimally invasive surgical stapling solutions designed to simplify various surgical procedures such as cholecystectomy, bariatric surgery, colectomy, appendectomy, and hysterectomy. Lexington Medical's products are intended for healthcare providers, aiming to enhance the efficiency and reliability of surgical operations through innovative design engineering and smart manufacturing processes.

Soffio Medical, Inc. is a Boston-based company focused on developing innovative medical devices for respiratory diseases. The firm specializes in implantable technologies that aim to address chronic obstructive pulmonary disease (COPD) and similar conditions. Its devices are designed to implement an airway bypass concept, allowing for the venting of trapped air from areas distal to high-resistance airways. This approach helps reduce residual lung volume and alleviates symptoms associated with respiratory diseases, ultimately enhancing the quality of life for patients.

Arterys Inc. is a pioneering company in the field of medical imaging analytics, focused on transforming healthcare through advanced radiology solutions. Established in 2007 and headquartered in San Francisco, California, with additional offices in Calgary, Canada, and Paris, France, Arterys offers a web-based, AI-powered platform that is FDA-cleared and designed to enhance patient care. Its suite of products includes Cardio AI for cardiac magnetic resonance image analysis, Lung AI for lung imaging, Liver AI for liver imaging, and Chest/MSK AI, which automates the detection of various conditions such as fractures and pulmonary nodules. Additionally, the Arterys PHI Service allows physicians to access patient data remotely. The platform's innovative technology enables radiologists to visualize and quantify blood flow in the human body, facilitating improved diagnostic capabilities and clinical decision-making.

Arterys Inc. is a pioneering company in the field of medical imaging analytics, focused on transforming healthcare through advanced radiology solutions. Established in 2007 and headquartered in San Francisco, California, with additional offices in Calgary, Canada, and Paris, France, Arterys offers a web-based, AI-powered platform that is FDA-cleared and designed to enhance patient care. Its suite of products includes Cardio AI for cardiac magnetic resonance image analysis, Lung AI for lung imaging, Liver AI for liver imaging, and Chest/MSK AI, which automates the detection of various conditions such as fractures and pulmonary nodules. Additionally, the Arterys PHI Service allows physicians to access patient data remotely. The platform's innovative technology enables radiologists to visualize and quantify blood flow in the human body, facilitating improved diagnostic capabilities and clinical decision-making.

Daktari Diagnostics, Inc. is a healthcare solutions company based in Cambridge, Massachusetts, focused on developing portable point-of-care diagnostic platforms to enhance disease management globally. Founded in 2008, the company offers several innovative products, including Daktari Virology for the detection of Hepatitis C and HIV, Daktari InSight, a cloud-based data management service, and Daktari Sickle Cell, which identifies infants with sickle cell disease from a single drop of blood. Daktari’s technology is designed specifically for resource-poor markets, featuring built-in wireless connectivity that facilitates real-time data sharing among healthcare providers. By delivering critical diagnostic information efficiently, Daktari aims to improve clinical outcomes and support global health initiatives. The company's commitment to affordability and quality ensures that its products are accessible to healthcare professionals and patients worldwide.

Vaxess Technologies, Inc. is a biotechnology company based in Boston, Massachusetts, founded in 2011. The company specializes in the development and commercialization of silk biomaterial technologies, particularly the MIMIX microneedle platform, which facilitates transdermal delivery of vaccines and therapeutics. This innovative sustained release patch technology enhances vaccine administration by simulating a natural infection, promoting a robust and prolonged immune response, thereby improving vaccine effectiveness. Additionally, Vaxess’s MATRIX formulation and drying platform creates thermostable vaccines, therapeutics, and diagnostic products that do not require refrigeration, making them suitable for distribution in low-resource settings. Through these advanced solutions, Vaxess aims to improve patient outcomes in oncology care and infectious diseases while reducing treatment burdens for healthcare practitioners.

Daktari Diagnostics, Inc. is a healthcare solutions company based in Cambridge, Massachusetts, focused on developing portable point-of-care diagnostic platforms to enhance disease management globally. Founded in 2008, the company offers several innovative products, including Daktari Virology for the detection of Hepatitis C and HIV, Daktari InSight, a cloud-based data management service, and Daktari Sickle Cell, which identifies infants with sickle cell disease from a single drop of blood. Daktari’s technology is designed specifically for resource-poor markets, featuring built-in wireless connectivity that facilitates real-time data sharing among healthcare providers. By delivering critical diagnostic information efficiently, Daktari aims to improve clinical outcomes and support global health initiatives. The company's commitment to affordability and quality ensures that its products are accessible to healthcare professionals and patients worldwide.

Syncro Medical Innovations, Inc. develops magnetically guided enteral feeding tubes. The company’s feeding tube contains magnetic field sensor at the distal end, electrically connected to a light indicator at the proximal end of the tube. Syncro Medical Innovations, Inc. was founded in 1998 and is based in Macon, Georgia.

Svelte Medical Systems, founded in 2007 by Robert Fischell, David Fischell, and Tim Fischell, specializes in the design, development, and commercialization of balloon-expandable stents for treating atherosclerosis via percutaneous coronary intervention (PCI). The company offers two primary products: SLENDER Integrated Delivery System (IDS), a drug-eluting stent-on-a-wire system that facilitates transradial interventions by downsizing catheters; and DIRECT Rapid Exchange System (RX), a drug-eluting stent designed to enhance direct stenting and high-pressure post-dilatations. Svelte aims to improve stent deliverability, reduce costs, and enhance safety compared to existing market products in the $5 billion coronary stent market.

Daktari Diagnostics, Inc. is a healthcare solutions company based in Cambridge, Massachusetts, focused on developing portable point-of-care diagnostic platforms to enhance disease management globally. Founded in 2008, the company offers several innovative products, including Daktari Virology for the detection of Hepatitis C and HIV, Daktari InSight, a cloud-based data management service, and Daktari Sickle Cell, which identifies infants with sickle cell disease from a single drop of blood. Daktari’s technology is designed specifically for resource-poor markets, featuring built-in wireless connectivity that facilitates real-time data sharing among healthcare providers. By delivering critical diagnostic information efficiently, Daktari aims to improve clinical outcomes and support global health initiatives. The company's commitment to affordability and quality ensures that its products are accessible to healthcare professionals and patients worldwide.

Intelligent Bio-Systems, established in 2005 by Drs. Steven J. Gordon and Jingyue Ju, specializes in developing advanced DNA sequencing systems. The company aims to enhance speed and reduce costs for generating sequence data, catering to both research and clinical applications, particularly in areas like cancer and HIV/AIDS studies. Their systems enable customers to achieve high-throughput sequencing at affordable prices while maintaining data quality.

Rhythmia Medical, Inc., founded in 2016, specializes in developing innovative medical devices aimed at treating cardiac arrhythmias. The company's primary focus lies in creating a state-of-the-art 3D mapping system designed to enhance catheter ablation procedures used to treat tachy-arrhythmias like atrial fibrillation. Rhythmia Medical aims to improve the visualization and navigation aspects of these critical procedures, thereby potentially enhancing patient outcomes.

Syncro Medical Innovations, Inc. develops magnetically guided enteral feeding tubes. The company’s feeding tube contains magnetic field sensor at the distal end, electrically connected to a light indicator at the proximal end of the tube. Syncro Medical Innovations, Inc. was founded in 1998 and is based in Macon, Georgia.